Consortium removes barriers to drug discovery, raises hope for rare disease cures

Structural Genomics Consortium (SGC), the Canadian-led consortium of pharmaceutical companies, clinicians and academia, supports open-access drug discovery around the world. And it’s bringing hope to the 300 million people afflicted by rare diseases and a world ravaged by COVID-19. 

A deep dive on Canadians’ relationship with the ocean

As the nation with the longest coastline in the world, Canada’s environment, economy, and overall health are deeply influenced by the ocean — perhaps more than many Canadians realize. This idea led Dr. Glithero and her team to measure Canadians’ understanding of the impact of the ocean on their lives, and in turn the impact their daily activities have on marine ecosystems.